{"transactions":[{"id":750859,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T23:44:43.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested immediately, and 25% of the shares subject to the option will vest on each one-year anniversary of the grant date over the next three years."}],"balance_after":190000,"derivative":{"exercise_price":31.27,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001193125-26-256039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526256039/ownership.xml","form_type":"4"}},{"id":1691889,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:04:40.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":90000,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-24-000326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000326/doc4.xml","form_type":"4"}},{"id":1691888,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-03T21:04:40.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3073,"price":0.8217,"value":2525.0841,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2024, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on December 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":93405,"source":{"system":"sec-edgar","filing":"0001209191-24-000326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000326/doc4.xml","form_type":"4"}},{"id":1691887,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-03T21:04:40.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":96478,"source":{"system":"sec-edgar","filing":"0001209191-24-000326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000326/doc4.xml","form_type":"4"}},{"id":1767183,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T20:29:10.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":97500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-23-051484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051484/doc4.xml","form_type":"4"}},{"id":1767182,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-03T20:29:10.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2593,"price":0.662,"value":1716.566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on September 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":88978,"source":{"system":"sec-edgar","filing":"0001209191-23-051484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051484/doc4.xml","form_type":"4"}},{"id":1767181,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-03T20:29:10.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":91571,"source":{"system":"sec-edgar","filing":"0001209191-23-051484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051484/doc4.xml","form_type":"4"}},{"id":1817769,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-02T21:58:53.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":74257,"price":1.01,"value":74999.57,"ownership":{"direct":true},"balance_after":84071,"source":{"system":"sec-edgar","filing":"0001209191-23-044282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123044282/doc4.xml","form_type":"4"}},{"id":1835856,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:08:19.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":105000,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-23-040978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040978/doc4.xml","form_type":"4"}},{"id":1835855,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-07-05T20:08:19.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2593,"price":1.04,"value":2696.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on June 30, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":9814,"source":{"system":"sec-edgar","filing":"0001209191-23-040978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040978/doc4.xml","form_type":"4"}},{"id":1835854,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-07-05T20:08:19.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":12407,"source":{"system":"sec-edgar","filing":"0001209191-23-040978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040978/doc4.xml","form_type":"4"}},{"id":1927734,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:17:18.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-23-023076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023076/doc4.xml","form_type":"4"}},{"id":1927733,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-04-05T00:17:18.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2593,"price":1.01,"value":2618.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on March 31, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":4907,"source":{"system":"sec-edgar","filing":"0001209191-23-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023076/doc4.xml","form_type":"4"}},{"id":1927732,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-04-05T00:17:18.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-23-023076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023076/doc4.xml","form_type":"4"}},{"id":1990181,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T01:15:42.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":120000,"derivative":{"underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-23-013450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123013450/doc4.xml","form_type":"4"}},{"id":2238994,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-08T20:24:41.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Inducement Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean June 7, 2022."}],"balance_after":250000,"derivative":{"exercise_price":1.3,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-22-035031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919122035031/doc4.xml","form_type":"4"}},{"id":2702467,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-20T22:54:06.000Z","date":"2021-05-20","kind":"purchase","acquired":true,"shares":3289,"price":3.6,"value":11840.4,"ownership":{"direct":true},"balance_after":3289,"source":{"system":"sec-edgar","filing":"0001209191-21-034595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622297/000120919121034595/doc4.xml","form_type":"4"}},{"id":2862335,"issuer":{"id":115177,"kind":"organization","name":"Metacrine, Inc.","symbol":"MTCR"},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:01:47.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on the one year anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on February 10, 2025."}],"balance_after":90000,"derivative":{"exercise_price":10.09,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-010204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622297/000120919121010204/doc4.xml","form_type":"4"}},{"id":4079161,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-02T20:06:08.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":78407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2018."}],"balance_after":78407,"derivative":{"exercise_price":3.38,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":78407},"source":{"system":"sec-edgar","filing":"0000899243-18-002749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318002749/doc4.xml","form_type":"4"}},{"id":4409428,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":41623,"kind":"person","name":"Chen Hubert C","position":1,"cik":"0001622297","reported_name":"Chen Hubert C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-02T17:11:42.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% shall vest on the one year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2017."}],"balance_after":85000,"derivative":{"exercise_price":7.47,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-17-006107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924317006107/doc4.xml","form_type":"4"}}]}